Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Canine Brain-Derived Neurotrophic Factor (BDNF), N-His

Cat. No.AP1C21

Product TypeAnimal Proteins

Size

Product Overview

BioVenic's Recombinant Canine Brain-Derived Neurotrophic Factor (BDNF), N-His is a recombinant protein expressed from E.coli. Its predicted molecular weight is 14.4 kDa. The purity is>90% (SDS-PAGE).

Specifications

Type Recombinant Protein
Species Canine
Expression System E.coli
Purity >90% (SDS-PAGE)
Endotoxin < 1 EU/µg
Predicted Molecular Weight 14.4 kDa
Molecular Weight 17.0 kDa
Physical State Lyophilized
Formulation The buffer before lyophilization is 100mMNaHCO3, 500mMNaCl, pH8.3, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.

Target Information

Canine brain-derived neurotrophic factor (BDNF) is a neurotrophin that belongs to the NGF-beta family, playing a crucial role in neuronal development, survival, and differentiation. It modulates neurotransmitter activity and is essential for neuronal plasticity, which is vital for learning and memory. BDNF is widely expressed in the central nervous system and is associated with neurodegenerative diseases when its levels decrease.

Protein Canine Brain-Derived Neurotrophic Factor (BDNF)
Protein Synonym Neurotrophin; Abrineurin
Gene ID 403461
UniProt ID Q7YRB4

Shipping and Storage

This product is shipped with dry ice. It is recommended to aliquote as needed and store at -80°C upon receipt. Reconstituted protein solution can be stored at 4°C for 1 week, at < -80°C for 12 months.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL.Aliquote the reconstituted solution to minimise freeze-thaw cycles.
Inquiry Basket